Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.

Michael DavidsonJay SaoudCorinne StanerNadine NoelSandra WernerElisabeth LuthringerDavid WallingMark WeiserPhilip D HarveyGregory P StraussRemy Luthringer

Published in: Schizophrenia bulletin (2022)

Results of this trial confirm the potential of roluperidone as a treatment of negative symptoms and improving everyday functioning in patients with schizophrenia. Study registration: Eudra-CT: 2017-003333-29; NCT03397134.

Keyphrases

computed tomography
bipolar disorder
depressive symptoms
risk assessment
replacement therapy
phase ii
double blind